Aim To evaluate the efficacy (rate of recanalization) of therapy with novel oral anticoagulants (NOAC; rivaroxaban, apixaban)compared to conventional treatment (low molecular weight heparin - LMWH and vitamin K antagonist) in the treatment of deep vein thrombosis (DVT) of the proximal segments of lower extremities.Methods The first group consisted ...

By Alden Begić, Edin Begić, Mirza Dilić, Svjetlana Loga - Zec, Nermina Babić, Refet Gojak, Armin Šljivo